So then does that mean that if you dont have EBV infection this isnt going to help you?
wdb wrote: But what I don't get is why the hell no one criticised the PACE trial for the same things, not only was it not double blind or even single blind, had a non comparable control group, and used the Chalder scale which also measures change in fatigue, where were their methodological concerns when that was published.
Esther12 wrote: People here had raised concerns about the difficulty of genuine blinding with a drug like Rituximab and the danger of placebo affects distorting results, the difficulty of assessing improvements, etc, etc. Some researchers only seem interested in making these sorts of criticisms of non-psychiatric CFS work, while trying to ignore the problems with research like PACE. Their talk of the needing a theoretical justification is particularly amusing in light of the way research undermining the role of both deconditioning and fear of activity as perpetuating factors in CFS was addressed in the Lancet's accompanying PACE editorial.
Esther12: I think PACE has made me much more cautious about trusting the claims made as part of any study!
Battery Muncher wrote: So I think it's useful to compare PACE with the Rituximab, to show that the psychiatric establishment hasn't got a leg to stand on - at least when it comes to criticising the rigour of the latter trial.
Nielk wrote: I agree that it's biased and unspeakable that PACE was not thrown out first hand but, is that a reason not to be cautious with any other study?
Thanks for posting this and the link to the calc; my spreadsheet calculates the same scores (for PF) as you. I remain baffled as to why Fluge et al didn't make more of these figures. Sure, they are a secondary outcome, and peak scores, but they are VASTLY better than for any other published trial. A couple of points:If anyone is curious about back calculation of the raw SF-36 scores using the calculator:
Baseline (raw) for Rituxumab group: PF 44.8
Max Change (raw): PF 76.5
Note, I hope I didn't make any mistakes.
Thanks for posting this and the link to the calc; my spreadsheet calculates the same scores (for PF) as you. I remain baffled as to why Fluge et al didn't make more of these figures. Sure, they are a secondary outcome, and peak scores, but they are VASTLY better than for any other published trial.
Also the primary outcome measure was at 3 months and it didn't go well for that date.Could it be that they didn't make more of them because they are not familiar with the literature evaluating ME treatments (and how poor some of the outcomes are)?
Jenny
Here's the full article: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936947/pdf/keq159.pdf
I liked this paragraph: on p.1912, just above "Materials and methods": "Our finding clearly show that RA patients having EBV replication at baseline, not only cleared their EBV load, but responded significantly better to the RTX treatment and presented a longer lasting response than patients who do not have EBV replication in the bone marrow.
I honestly think that within CFS there are subsets of patients who have one or more pathogen making them sick. I'm guessing that Elene got well because the rituximab got rid of her chronic EBV infection: http://bergento.no/?page_id=3242&preview=true
But, rituximab doesn't work on all infections that may be behind CFS. So, not everyone gets the same amount of benefit from the drug. It is very exciting to me to see these articles.....
Best, Timaca
One thing I've learned after being ill over 20 years (and severely affected over 17 years) is that non-pharmacologic treatment incl. supplements probably won't be enough to get me back on my feet. The choice then becomes a bit starker.One thing I have learned after having this illness for years- I will not allow anything to be injected into my body. No way, no how. That is a sure fire way to get worse!
Rituximab will turn out to be a red herring, just like XMRV. This illness is metabolic not infectious, imho. Google the work of Dr. Steven Rochlitz for the best theory I have heard yet on so-called "mystery illnesses".
One thing I've learned after being ill over 20 years (and severely affected over 17 years) is that non-pharmacologic treatment incl. supplements probably won't be enough to get me back on my feet. The choice then becomes a bit starker.
I am as ill as I say I am and I was/am severely affected whether I was or was not taking a pharmaceutical.If you are as ill as you say, I would imagine you are taking some toxic pharmaceuticals?
Rituximab will turn out to be a red herring, just like XMRV. This illness is metabolic not infectious, imho.".